Moleculin Biotech, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $38.2M
Liabilities Breakdown FY2023
Total Liabilities: $12.1M
Asset Breakdown
Total Assets: $38.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $23.6M | 61.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $272.0K | 0.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $14.4M | 37.7% |
Liabilities Breakdown
Total Liabilities: $12.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.5M | 20.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $9.6M | 79.4% |